Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile
Journal of Medicinal Chemistry · 08.05.2025 · 68 (9) · 9357-9370
DOI: 10.1021/acs.jmedchem.4c03090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.04.2025. Verfasst von Jingdong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States. Hauptthemen laut MEDLINE: Clostridioides difficile, Spores, Bacterial, Bacterial Proteins, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Clostridioides difficile, a Gram-positive, spore-forming anaerobic bacterium, is a major healthcare threat. Its spores colonize the gut following dysbiosis caused by broad-spectrum antibiotics, remaining dormant until host's bile acid triggers germination into vegetative cells that produce toxins, leading to diarrhea, colitis, and potentially death. Current antibiotics to treat C. difficile infection target vegetative cells but not spore germination, a pivotal step in infection development. This study unveils 1,2,4-oxadiazoles as a novel class of spore germination inhibitors and delineates the structure-activity relationship. Screening of 120 oxadiazoles revealed compound 110 (IC50 = 14 ± 1 μM or 6.3 ± 0.4 μg/mL). Compound 110 targets mature SleC (Kd = 12 ± 1.0 μM) and CspB (Kd = 8.0 ± 1.0 μM) on spores, inhibiting their enzymatic activities, thus preventing spore germination. To our knowledge, compound 110 is the first reported spore germination inhibitor targeting SleC/CspB, offering a promising avenue for C. difficile therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
ORCID-Profile: Jingdong Yang, Choon Kim, Biruk T Birhanu, Shahriar Mobashery, Mayland Chang
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Yang, J., Qian, Y., Kim, C., Birhanu, B. T., Cal Y Mayor-Luna, C., Ding, D., Yu, X., Schroeder, V. A., Mobashery, S., & Chang, M. (2025). Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile. Journal of Medicinal Chemistry, 68(9), 9357-9370. https://doi.org/10.1021/acs.jmedchem.4c03090
Vancouver
Yang J, Qian Y, Kim C, Birhanu BT, Cal Y Mayor-Luna C, Ding D, et al. Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile. Journal of Medicinal Chemistry. 2025;68(9):9357-9370. doi:10.1021/acs.jmedchem.4c03090
BibTeX
@article{Yang2025,
author = {Yang, Jingdong and Qian, Yuanyuan and Kim, Choon and Birhanu, Biruk T and Cal Y Mayor-Luna, Carlos and Ding, Derong and Yu, Xiaotan and Schroeder, Valerie A and Mobashery, Shahriar and Chang, Mayland},
title = {Targeting SleC and CspB in the Inhibition of Spore Germination in Clostridioides difficile},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {9},
pages = {9357--9370},
doi = {10.1021/acs.jmedchem.4c03090}
}
EUVIMED